3rjm
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | [[Image:3rjm.jpg|left|200px]] | |
- | The | + | <!-- |
+ | The line below this paragraph, containing "STRUCTURE_3rjm", creates the "Structure Box" on the page. | ||
+ | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
+ | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
+ | or leave the SCENE parameter empty for the default display. | ||
+ | --> | ||
+ | {{STRUCTURE_3rjm| PDB=3rjm | SCENE= }} | ||
- | + | ===CASPASE2 IN COMPLEX WITH CHDI LIGAND 33c=== | |
- | + | ||
+ | <!-- | ||
+ | The line below this paragraph, {{ABSTRACT_PUBMED_21903398}}, adds the Publication Abstract to the page | ||
+ | (as it appears on PubMed at http://www.pubmed.gov), where 21903398 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_21903398}} | ||
+ | |||
+ | ==About this Structure== | ||
+ | [[3rjm]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3RJM OCA]. | ||
+ | |||
+ | ==Reference== | ||
+ | <ref group="xtra">PMID:021903398</ref><references group="xtra"/> | ||
+ | [[Category: Caspase-2]] | ||
+ | [[Category: Homo sapiens]] | ||
+ | [[Category: Abendroth, J.]] | ||
+ | [[Category: Kiselyov, A S.]] | ||
+ | [[Category: Lorimer, D.]] | ||
+ | [[Category: Maillard, M.]] | ||
+ | [[Category: Stewart, L.]] | ||
+ | [[Category: Caspase]] | ||
+ | [[Category: Caspase-2]] | ||
+ | [[Category: Hydrolase-hydrolase inhibitor complex]] | ||
+ | [[Category: P12]] | ||
+ | [[Category: P19]] |
Revision as of 06:03, 21 September 2011
CASPASE2 IN COMPLEX WITH CHDI LIGAND 33c
Template:ABSTRACT PUBMED 21903398
About this Structure
3rjm is a 6 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Maillard MC, Brookfield FA, Courtney SM, Eustache FM, Gemkow MJ, Handel RK, Johnson LC, Johnson PD, Kerry MA, Krieger F, Meniconi M, Munoz-Sanjuan I, Palfrey JJ, Park H, Schaertl S, Taylor MG, Weddell D, Dominguez C. Exploiting differences in caspase-2 and -3 S(2) subsites for selectivity: Structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors. Bioorg Med Chem. 2011 Oct 1;19(19):5833-51. Epub 2011 Aug 16. PMID:21903398 doi:10.1016/j.bmc.2011.08.020